01 Shift toward Procedure-Specific Thread Materials The aesthetic threads market analysis shows that demand for personalized facial rejuvenation is shifting thread selection toward materials suited to specific lifting and skin-rejuvenation needs. This transition allows practitioners to consider differences in absorption time, tissue response, and collagen stimulation when selecting polydioxanone (PDO), poly-L-lactic acid (PLLA), or polycaprolactone (PCL) threads. A 2025 clinical review covering 12 studies and 818 patients found that PDO was the most frequently evaluated thread material, followed by PLLA/PCL threads, while also noting limited evidence on long-term effectiveness.
02 Absorbable Threads for Non-Surgical Facial Rejuvenation Demand for minimally invasive facial contouring is shifting the aesthetic threads market toward absorbable materials that provide temporary tissue support and may stimulate collagen production during degradation. This transition offers an alternative to conventional surgical lifting, although treatment duration and rejuvenation outcomes depend on the thread material, technique, and patient characteristics. A 2025 consensus statement from the Association of Cutaneous Surgeons of India identifies PDO, PLLA, and PCL as materials used in thread-lifting procedures but notes that strong clinical evidence for long-term rejuvenation remains limited.
September 2025 Meditox expanded its aesthetic healthcare portfolio by advancing cosmetic treatment solutions, including minimally invasive procedures using innovative thread-based technologies. The company focused on enhancing aesthetic treatment options and patient experiences.
July 2025 Croma-Pharma expanded its aesthetic medicine portfolio by strengthening its PDO thread solutions and professional training programs. The developments focused on improving clinical outcomes and expanding minimally invasive aesthetic treatments.
June 2025 Aptos expanded its aesthetic thread solutions by introducing enhanced thread lifting products featuring improved biomaterial designs and treatment techniques. The company focused on supporting non-surgical facial contouring and skin rejuvenation procedures.
May 2025 Sinclair Pharma expanded its aesthetic threads portfolio by advancing absorbable thread technologies designed for minimally invasive facial rejuvenation procedures. The developments focused on improving lifting effects, patient comfort, and treatment outcomes.